Correlation Between PVI Reinsurance and Daklak Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both PVI Reinsurance and Daklak Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PVI Reinsurance and Daklak Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PVI Reinsurance Corp and Daklak Pharmaceutical Medical, you can compare the effects of market volatilities on PVI Reinsurance and Daklak Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PVI Reinsurance with a short position of Daklak Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of PVI Reinsurance and Daklak Pharmaceutical.

Diversification Opportunities for PVI Reinsurance and Daklak Pharmaceutical

0.0

Correlation Coefficient

PVI Reinsurance  Daklak Pharmaceutical

Pay attention - limited upside

The 3 months correlation between PVI and Daklak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding PVI Reinsurance Corp and Daklak Pharmaceutical Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daklak Pharmaceutical and PVI Reinsurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PVI Reinsurance Corp are associated (or correlated) with Daklak Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daklak Pharmaceutical has no effect on the direction of PVI Reinsurance i.e., PVI Reinsurance and Daklak Pharmaceutical go up and down completely randomly.

Pair Corralation between PVI Reinsurance and Daklak Pharmaceutical

If you would invest  1,800,000  in PVI Reinsurance Corp on September 24, 2024 and sell it today you would earn a total of  180,000  from holding PVI Reinsurance Corp or generate 10.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

PVI Reinsurance Corp  vs.  Daklak Pharmaceutical Medical

PVI Reinsurance Corp

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in PVI Reinsurance Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, PVI Reinsurance may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Daklak Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Daklak Pharmaceutical Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Daklak Pharmaceutical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with PVI Reinsurance and Daklak Pharmaceutical

The main advantage of trading using opposite PVI Reinsurance and Daklak Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PVI Reinsurance position performs unexpectedly, Daklak Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daklak Pharmaceutical will offset losses from the drop in Daklak Pharmaceutical's long position.

The idea behind PVI Reinsurance Corp and Daklak Pharmaceutical Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.